acute myeloid leukemia (AML) | Page 35 | Aplastic Anemia & MDS International Foundation Return to top.

acute myeloid leukemia (AML)

Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia

Natalie Ertz-Archambault, MD; Heidi Kosiorek, MS; Gretchen E. Taylor, MD; et al Katalin Kelemen, MD, PhD; Amylou Dueck, PhD; Janna Castro, BS; Robert Marino, MS; Susanne Gauthier, RN; Laura Finn, MD; Lisa Z. Sproat, MD; Jeanne Palmer, MD; Ruben A. Mesa
Primary Author: 
Natalie Ertz-Archambault, MD
Journal Title: 
JAMA Oncol
Original Publication Date: 
Feb 2017

Importance  Therapy-related myeloid neoplasms are a potentially life-threatening consequence of treatment for autoimmune disease (AID) and an emerging clinical phenomenon.

Six Areas of Care

In consultation with expert health professionals, we are highlighting 6 aspects of care that are common to all patients. We encourage you to pay attention to each of them, as they are part of everyday life and will impact your body's needs. You'll also feel better if you take the recommended actions.  

Share with